Concord Biotech Ltd (CONCORDBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10038977, "name": "Concord Biotech", "stock_name": "Concord Biotech", "full_name": "Concord Biotech Ltd", "name_url": "stocks-analysis/concord-biotech", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,318.95", "chg": -20.9, "chgp": "-1.56%", "dir": -1, "prev_price": "1,339.85", "mcapval": "14,124.00 Cr", "mcap": "Small Cap", "scripcode": 543960, "symbol": "CONCORDBIO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE338H01029", "curr_date": "Jun 23, 03:30 PM", "curr_time": "00:00 AM", "last_traded_at": "Jun 23, 03:30 PM IST", "bse_nse_vol": "1.01 lacs", "exc_status": "Active", "traded_date": "Jun 23, 2026", "traded_date_str": "2026 06 23", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concord-biotech-10038977-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Concord Biotech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-sell-4067185", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_mojoScore_4067185.png", "date": "2026-06-22 10:12:01", "description": "Concord Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 June 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook." }, { "title": "Concord Biotech Ltd Faces Technical Momentum Shift Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-faces-technical-momentum-shift-amid-mixed-market-signals-4060484", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_technicaldot_4060484.png", "date": "2026-06-18 08:05:36", "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Recent technical parameter changes have prompted a downgrade in its Mojo Grade from Hold to Sell, signalling caution for investors amid sideways price action and mixed indicator readings." }, { "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-4058267", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_technicaldot_4058267.png", "date": "2026-06-17 08:06:40", "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes." }, { "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-4055228", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_technicaldot_4055228.png", "date": "2026-06-16 08:07:43", "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a 2.01% gain on 16 Jun 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, prompting a downgrade in its Mojo Grade from Hold to Sell." }, { "title": "Concord Biotech Gains 15.43%: 5 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-gains-1543-5-key-factors-driving-the-weeks-rally-4051816", "imagepath": "", "date": "2026-06-13 15:11:50", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Stock opens week at Rs.1,060.60 with 1.12% gain despite Sensex decline</p>\n <p><strong>2 June:</strong> Intraday high of Rs.1,147.20 with 8.53% daily surge</p>\n <p><strong>3 June:</strong> Significant gap up and intraday high of Rs.1,255.15; heavy trading volume</p>\n <p><strong>4 June:</strong> Technical momentum shifts amid mixed signals; 2.86% daily gain</p>\n <p><strong>5 June:</strong> Week closes at Rs.1,210.65, down 2.19% on the day but up for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\"..." }, { "title": "Concord Biotech Gains 11.83%: 4 Key Technical Shifts Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-gains-1183-4-key-technical-shifts-driving-the-week-4050715", "imagepath": "", "date": "2026-06-13 09:07:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>8 Jun:</strong> Stock opens week at ₹1,197.50 amid broader market weakness</p>\n <p><strong>9 Jun:</strong> Technical momentum shifts amid mixed market signals; stock surges 6.18%</p>\n <p><strong>10 Jun:</strong> MarketsMOJO upgrades rating to Hold as technicals improve</p>\n <p><strong>11 Jun:</strong> Mildly bullish technical momentum confirmed with 4.35% gain</p>\n <p><strong>12 Jun:</strong> Week closes at ₹1,353.85, up 11.83% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-v..." }, { "title": "Concord Biotech Upgraded to Hold as Technicals Improve Despite Flat Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-upgraded-to-hold-as-technicals-improve-despite-flat-financials-4046096", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_mojoScore_4046096.png", "date": "2026-06-11 08:33:31", "description": "Concord Biotech Ltd has seen its investment rating upgraded from Sell to Hold as of 10 June 2026, reflecting a nuanced improvement in its technical outlook alongside stable financial metrics. Despite challenges in long-term growth and valuation concerns, the company’s enhanced technical indicators and solid management efficiency have prompted a reassessment of its market stance." }, { "title": "Concord Biotech Ltd Technical Momentum Shifts Signal Mild Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-4045971", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_technicaldot_4045971.png", "date": "2026-06-11 08:05:31", "description": "Concord Biotech Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, supported by a 4.35% gain on 11 Jun 2026. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and volume trends suggest cautious optimism for investors in the pharmaceuticals and biotechnology sector." }, { "title": "Concord Biotech Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-sell-4044075", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_mojoScore_4044075.png", "date": "2026-06-10 10:10:05", "description": "Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 422, "sid": "10038977", "stock_news_url": "https://www.marketsmojo.com/news/concord-biotech-10038977" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Acquisition", "datetime": "20-Jun-2026", "details": "We are pleased to announce that the Company has entered into an agreement to Invest in M/s. FSGE Renewable Power Private Limited for installation of Wind Solar Hybrid Power Project having a wind capacity of approximately 6.3 MW AC & solar capacity of approximately 6.3 MWp DC in Gujarat for Limbasi Facility of the Company.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "19-Jun-2026", "details": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 scheduled to be held on 24th & 25th June 2026.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "13-Jun-2026", "details": "Intimation of Schedule of Analyst / Institutional Investor meeting to be held on June 17 2026 at 10:30 AM", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Concord Biotech Ltd has declared <strong>1070%</strong> dividend, ex-date: 03 Sep 25", "dt": "2025-09-03", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Stock opens week at Rs.1,060.60 with 1.12% gain despite Sensex decline

2 June: Intraday high of Rs.1,147.20 with 8.53% daily surge

3 June: Significant gap up and intraday high of Rs.1,255.15; heavy trading volume

4 June: Technical momentum shifts amid mixed signals; 2.86% daily gain

5 June: Week closes at Rs.1,210.65, down 2.19% on the day but up for the week

Read full news article

Concord Biotech Gains 11.83%: 4 Key Technical Shifts Driving the Week

2026-06-13 09:07:56

Key Events This Week

8 Jun: Stock opens week at ₹1,197.50 amid broader market weakness

9 Jun: Technical momentum shifts amid mixed market signals; stock surges 6.18%

10 Jun: MarketsMOJO upgrades rating to Hold as technicals improve

11 Jun: Mildly bullish technical momentum confirmed with 4.35% gain

12 Jun: Week closes at ₹1,353.85, up 11.83% for the week

Week Open

Read full news article

Concord Biotech Upgraded to Hold as Technicals Improve Despite Flat Financials

2026-06-11 08:33:31

Concord Biotech Ltd has seen its investment rating upgraded from Sell to Hold as of 10 June 2026, reflecting a nuanced improvement in its technical outlook alongside stable financial metrics. Despite challenges in long-term growth and valuation concerns, the company’s enhanced technical indicators and solid management efficiency have prompted a reassessment of its market stance.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Signal Mild Bullish Outlook

2026-06-11 08:05:31

Concord Biotech Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, supported by a 4.35% gain on 11 Jun 2026. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and volume trends suggest cautious optimism for investors in the pharmaceuticals and biotechnology sector.

Read full news article

Concord Biotech Ltd is Rated Sell

2026-06-10 10:10:05

Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News